| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_870c6e68c09f6b820fc9b7fefe1a56fc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-91 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0655 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
| filingDate |
2019-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77b8fed1dc20707799e3e19fba67e513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b9d6a9f0395c34dedd604be8997af28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee699346256ac9e19a35179b2ee5a9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d194315f509ec41c75a9cea87c2d27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e0975f291a4bcb89e3101f66bff407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c44c5e224caf11a7f54f1bc297dd3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a273d7f5d6c6a8924a25dd160a5d8f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca82835991db99e39755b91b8d87d5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82966c9715c3b5b78248c7ca25e8d1be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b1ef50ebd4d6228c6495a90c95ae70b |
| publicationDate |
2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112021005697-A2 |
| titleOfInvention |
methods to obtain cells derived from mesenchymal stem cells (msc) of chondro-osteoblastic lineage from msc, populations of cells derived from msc of chondro-osteoblastic lineage and pharmaceutical formulation |
| abstract |
methods to obtain cells derived from mesenchymal stem cells (msc) of chondro-osteoblastic lineage from msc, populations of cells derived from msc of chondro-osteoblastic lineage, and pharmaceutical formulation. The present invention provides methods for obtaining cells derived from mesenchymal stem cells (msc) of chondro-osteoblastic lineage from mcs. the invention also relates to a population of cells derived from msc of chondro-osteoblastic lineage obtained by the methods, a pharmaceutical formulation comprising the population of cells derived from msc of chondro-osteoblastic lineage and its use in the treatment of a subject in need of transplantation of chondro-osteoblastic lineage cells. |
| priorityDate |
2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |